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Methicillin-resistant Staphylococcus aureus (MRSA) is a constant therapeutic challenge in 
humans and animals, due to the limited range of antibiotics that can be used for the management of 
infections. This preliminary study is based on the assessment of the antibacterial activity of kuwanon G (a 
prenylated flavonoid present in white mulberry, Morus alba L., Moraceae) and its interactions with various 
antibiotics (oxacillin, amoxicillin, erythromycin and gentamicin) against four MRSA clinical isolates (MRSA 
T1 – T4). The sources of all clinical isolates resistant to cefoxitin and oxacillin were infections (recurrent 
otitis, pyoderma and laryngopharyngitis) in dogs. Minimum inhibitory concentrations (MICs) for kuwanon 
G and antibiotics were determined by the microdilution method. Interactions between kuwanon G and 
antibiotics were evaluated by the checkerboard method and time-kill assay. MICs varied between 6.25 and 
12.5µg/mL for kuwanon G alone against all four MRSA clinical isolates. According to the calculated 
fractional inhibitory concentration index, various combinations were synergistic and additive. Microbicidial 
time has confirmed the synergy as the logarithmic reductions of colony-forming units obtained for the 
combinations of kuwanon G and some antibiotics were 2log10 lower than the logarithmic reductions obtained 
for the most potent/active component of the combination. The obtained results are promising, taking into 
account the antibacterial activity of kuwanon G, as well as its synergistic effects with the most used 
antibiotics. This study reports on the antibacterial activity of kuwanon G and suggests its ability to act 
synergistically with antibiotics; combinations effective in combating Gram-positive including MRSA 
infections might be developed. 
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Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium that 
developed drug resistance to β-lactam antibiotics through horizontal gene transfer and natural multiple 
selections. Infections with MRSA are a real problem for humans and animals and the treatment of these 
infections is challenging due to the limited range of antibiotics that can be used because of antibiotic 
resistance (1 - 5). Kuwanon G (KG) is a prenylated flavonoid present in white mulberry (Morus alba 
L., Moraceae) leaves, fruits and root bark (fig. 1) (6, 7). 
The aim of this preliminary study was to investigate the antibacterial activity of kuwanon G 
















Material and methods 
For this study, there were selected four MRSA (MRSA T1 – T4) clinical strains resistant 
to oxacillin and cefoxitin. The strains were isolated from various infections (recurrent otitis, 
pyoderma and laryngopharyngitis) in dogs (phenotype being established by the diffusimetric 
method). 
Minimum inhibitory concentrations (MICs) of KG, oxacillin (OX), amoxicillin (Amx), 
erythromycin (Er) and gentamicin (Gn) against MRSA isolates were determined by the 
microdilution method according to current Clinical & Laboratory Standards Institute (CLSI) (8) 
and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (9). 
Two in vitro tests were performed in order to evaluate the interactions between KG and 
antibiotics: checkerboard method (10) and time-kill assay (11). The experimental design of 
checkerboard method involves the use of 96-well microtiter plates in order to evaluate the bacterial 
growth in the presence of the combination of two components (KG and antibiotic) in various 
concentrations after incubation at 370C for 24 hours. The absorbances were determinated 
spectophotometrically (450/650 nm) before and after incubation. MIC was defined as the 
concentration that reduced the bacterial growth by 80% compared to the bacterial culture control. 
Checkerboard method enables the interpretation of the results through fractional inhibitory 
concentration index (FICI) and isobolograms (12). 
 







M ICantibiotic in combination with kuwanon G, 
MICantibiotic alone 
 
= M ICkuwanon G in combination with antibiotic . kuwanon G MICkuwanon G alone 
 
A combination is synergistic if FICI value ≤ 0.5, additive when it is > 0.5 and ≤ 1, 
indifferent when it is 1 – 4, and antagonistic when it is > 4 (11). 
The results obtained the checkerboard method were subjected to Bliss independence–based 
model interpretation with graphical representation of the experimental dose-response surface and 
theoretical dose-response surface of interaction. Experimental dose-response surface (Emeasured) 
represents the experimental percentage of growth in the presence of different concentrations of KG 
and/or antibiotic. Taking into account the non-interactive process between two components, 
Epredicted is the calculated percentage of growth based on the experimental percentage of growth 
according to Bliss independence–based model. Theoretical dose-response surface of interaction 




growth with KG and antibiotic at various concentrations. Points of difference surface above zero 
(positive) indicate synergy and below zero (negative) indicate antagonism (10). 
In time-kill assay, the bactericidal effect of the combination of KG (at ½MICKG 
concentration) and antibiotic (at ½MICantibiotic concentration) was compared with the bactericidal 
effect of the antibiotic alone, KG alone and bacterial culture control. After 0, 4, 24 and 48 hours of 
incubation at 370C, aliquots were withdrawn and the colony forming units (CFU) were determined 
after incubation at 37˚C. Synergy/antagonism is interpreted if the combination increases/decreases 
by 100 (or 2log10) times the bactericidal effect, compared to the most potent/active antibacterial 
agent of the combination after 24 hours or 48 hours (11). 
 
Results and discussion 
MIC values of KG alone against all MRSA clinical isolates varied between 6.25 and 12.50 
µg/mL and the bacterial susceptibility of MSRA clinical isolates to tested antibiotics is presented 
in table 1. 
 
Table 1. MIC (µg/mL) of antibiotics and KG* 
MRSA clinical isolates MICOX MICAmx MICEr MICGn MICKG 
MRSA T1 16 (R) 16 (R) >170.67 (R) 0.25 (S) 12.50 
MRSA T2 128 (R) 128 (R) 10.67 (R) 0.25 (S) 6.25 
MRSA T3 256 (R) 256 (R) >170.67 (R) 0.50 (S) 12.50 
MRSA T4 256 (R) 256 (R) >170.67 (R) 1 (S) 12.50 
*European Committee on Antimicrobial Susceptibility - Testing Breakpoint tables for interpretation of 
MICs and zone diameter Version 7.0. Valid from 2017-01-01; Abbreviation: S – sensible, R – resistant 
 
 KG – OX combinations 
Checkerboard method showed synergies for the combinations KG – OX (FICI= 0.04-0.5; 
table 2, fig. 2a) against MRSA T1 – T4 clinical isolates. Time-kill assay did not confirm synergy 
for the combinations KG – OX against MRSA T1 –T4, but excluded the antagonism, because the 
combination of KG with antibiotics did not decrease, but also did not increase the viable colony 
count by more than 2log10CFU/mL compared to the viable count obtained with the most 
active/potent agent of combination (KG). These differences between the results obtained by the 
checkerboard method and time kill assay can be explained by the different measured phenomena – 
the checkerboard method assesses the inhibitory effect while the time kill assay measures the 
bactericidal process (13). 
 
Table 2. Effects of KG – OX combinations 








MRSA T1 16 0.50 0.01 0.20 12.25 0.03 0.04 (S) NC 
MRSA T2 128 0.50 0.01 0.20 6.25 0.03 0.04 (S) NC 
MRSA T3 256 0.50 0.01 1.56 12.5 0.13 0.14 (S) NC 
MRSA T4 256 0.50 0.01 6.25 12.5 0.50 0.50 (S) NC 
Abbreviation: S – synergy, NC – synergy has not been confirmed, MICOX–KG – MIC of OX in presence of 
KG, MICKG–OX – MIC of KG in presence of OX 
*effect of the combination determined through checkerboard method, ** effect of the combination determined 
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Figure 2. Interactions between KG – OX (a), KG – Amx (b), KG – Er (c) and KG – Gn (d) 
against MRSA clinical isolates T1 – T4; purple colored dotted circles highlight synergies. 
 
 
 KG – Amx combinations 
Checkerboard method showed synergy for the combinations KG – Amx (FICI=0.04-0.14; 
table 3, fig. 2b) against MRSA T1 - T3 clinical isolates and additive effects (FICI=0.51) against 
MRSA T4. Time-kill assay confirmed synergy for the combinations KG – Amx against MRSA T1 
– T2 (fig. 3), but excluded the antagonism against MRSA T3 –T4. 
 
Table 3. Effects of KG – Amx combinations 






(µg/mL) FICKG FICI 
* TKA** 
MRSA T1 16 0.50 0.01 0.20 12.25 0.03 0.04 (S) S 
MRSA T2 128 0.50 0.01 0.20 6.25 0.03 0.04 (S) S 
MRSA T3 256 0.50 0.01 1.56 12.5 0.13 0.14 (S) NC 
MRSA T4 256 0.50 0.01 6.25 12.5 0.50 0.51 (Ad) NC 
Abbreviation: S – synergy, NC – synergy has not been confirmed, MICAmx–KG – MIC of Amx in presence of 
KG, MICKG–Amx – MIC of KG in presence of Amx 
*effect of the combination determined through checkerboard method, ** effect of the combination determined 
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Figure 3. Time–kill curves of KG alone, Amx alone and their combination against 
MRSA T1 (a) and MRSA T2 (b). 
 
 
 KG – Er combinations 
Checkerboard method showed synergies for the combinations KG – Er (FICI=0.03-0.1; table 
4, fig. 2c) against MRSA T2 - T4 clinical isolates. Time-kill assay did not confirm synergy for 
combinations KG – Er against MRSA T2 –T4, but excluded the antagonism. It should be noted 
that KG did not decrease MICEr against MRSA T1. 
 
Table 4. Effects of KG – Er combinations 








MRSA T1 >170.67¥ 
(341.33) 
>170.67 ND 12.25 12.25 1 ND NC 
MRSA T2 1.00 0.10 0.52 6.25 0.00 0.10 (S) NC 
MRSA T3 10.67 0.33 0.03 0.13 12.5 0.04 0.07 (S) NC 
MRSA T4 >170.67
¥ 
(341.33) 8.00 0.02 12.5 12.5 0.01 0.03 (S) NC 
Abbreviation: S – synergy, NC – synergy has not been confirmed, MICEr–KG – MIC of Er in presence of KG, 
MICKG–Er – MIC of KG in presence of Er, ¥MICEr >170.67 µg/mL and for calculation of FICEr, MICEr was 
considered as being 341.33 µg/mL 
*effect of the combination determined through checkerboard method, ** effect of the combination determined 
through time-kill assay 
 
 
 KG – Gn combinations 
Checkerboard method showed synergies for the combinations KG – Gn (FICI=0.03-0.09; table 5, 
fig. 2d) against MRSA T1 – T4 clinical isolates. 




















Table 5. Effects of KG – Gn combinations 








MRSA T1 0.25 0.02 0.06 0.20 12.25 0.02 0.08 (S) S 
MRSA T2 0.25 0.02 0.06 0.20 6.25 0.03 0.09 (S) S 
MRSA T3 0.50 0.02 0.03 0.20 12.5 0.02 0.05 (S) S 
MRSA T4 1 0.02 0.02 0.20 12.5 0.02 0.03 (S) S 
Abbreviation: S – synergy, MICGn–KG – MIC of Gn in presence of KG, MICKG–Gn – MIC of KG in presence 
of Gn, *effect of the combination determined through checkerboard method, ** effect of the combination 
determined through time-kill assay 
 
 
The experimental percentage of growth (fig. 4a) in the presence of different concentrations 
of KG and/or Gn and the theoretical dose-response surface of interaction (fig. 4b) were represented 




Figure 4a. The three-dimensional plot of the experimental percentage of growth (Emeasured) 
between KG and Gn against MRSA T4. 
 
Figure 4b. Theoretical dose-response surface of interaction (ΔE) between KG and Gn against 




Time-kill assay confirms synergy for the combinations KG – Gn against MRSA T1 (fig. 
5a and fig. 6a), MRSA T2 (fig. 5b and fig. 6b), MRSA T3 (fig. 5c and fig. 6c) and MRSA T4 
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Figure 5. Time–kill curves of KG alone, Gn alone and their combinations against 
MRSA T1 (a), MRSA T2 (b), MRSA T3 (c), MRSA T4 (d). 
a. MRSA T1 b. MRSA T2 
c. MRSA T3 
   








































Figure 6. Differences between KG/Gn, Gn, KG against MRSA T1 (a), MRSA T2 (b), 
MRSA T3 (c), MRSA T4 (d) in time kill-assay determinations. 
 
Conclusion 
The results of this preliminary study highlight the antibacterial activity of kuwanon G and 
its ability to synergize with antibiotics – oxacillin, amoxicillin, erythromycin and gentamicin. The 
combinations: kuwanon G – oxacillin, kuwanon G – amoxicillin, kuwanon G – erythromycin and 
kuwanon G – gentamicin tested using the checkerboard method showed synergistic effects against 
MRSA clinical isolates. The synergistic effects were partially confirmed by the time-kill assay. 
This study reports on the antibacterial activity of kuwanon G and suggests its ability to act 
synergistically with antibiotics; combinations effective in combating Gram-positive including 
MRSA infections might be developed. 
 
References 
1. Fair RJ, Tor Y Antibiotics and Bacterial Resistance in the 21st Century. Perspect Medicin Chem. 
2014; 6: 25–64. 
2. Holmes NE, Howden BP. What's new in the treatment of serious MRSA infection? Curr Opin Infect 
Dis. 2014; 27(6): 471-8. 
3. Drebes J, Künz M, Pereira CA et al. MRSA infections: from classical treatment to suicide drugs. Curr 
Med Chem. 2014; 21(15):1809-19. 
4. Tverdek FP, Crank CW, Segreti J. Antibiotic therapy of methicillin-resistant Staphylococcus aureus 
in critical care. Crit Care Clin. 2008; 24(2): 249-60. 
5. Gurusamy KS, Koti R, Toon CD et al. Antibiotic therapy for the treatment of methicillin-resistant 
Staphylococcus aureus (MRSA) infections in surgical wounds. Cochrane Database Syst Rev. 2013; 
20 (8): CD009726. 
6. Gryn-Rynko A, Bazylak G, Olszewska-Slonina D. New potential phytotherapeutics obtained from 




7. Jung HW, Kang SY, Kang JS et al. Effect of Kuwanon G isolated from the root bark of Morus alba 
on ovalbumin-induced allergic response in a mouse model of asthma. Phytother Res. 2014; 
28(11):1713-9. 
8. CLSI. Performance Standards for Antimicrobial Susceptibility Testing 27th Edition, CLSI supplement 
M100. Wayne, PA: Clinical and Laboratory Standards Institutes; 2017. 
9. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation 
of MICs and zone diameters. Version 7.0, 2017. 
10. Segatore B, Bellio P, Setacci D et al. In vitro interaction of usnic acid in combination with antimicrobial 
agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and 
ΔE model methods. Phytomedicine 2012; 19(3-4):341-7. 
11. Mulyaningsih S, Sporer F, Zimmermann S et al. Synergistic properties of the terpenoids 
aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic- 
susceptible and antibiotic-resistant pathogens. Phytomedicine 2010; 17:1061-6. 
12. van Vuuren S, Viljoen A. Plant-based antimicrobial studies--methods and approaches to study the 
interaction between natural products. Planta Med 2011; 77(11): 1168-8. 
13. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of 
detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 1996; 
40(8):1914. 
